Our findings extend this concept by providing, to our knowledge, the first demonstration of a bidirectional TGF-β–furin regulatory loop in CRC, which sustains ERK activation and enhances proliferative and chemoresistant phenotypes. The gene discussed is TGFB1; the disease is colorectal carcinoma.